Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05348564 · ClinicalTrials.gov registry record · NA
Comparing Direct vs Indirect Methods for Cascade Screening
A NA study of Long QT Syndrome and Familial Hypercholesterolemia, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05348564: Recruiting NA study of Long QT Syndrome and Familial Hypercholesterolemia, sponsored by University of Maryland, Baltimore.
NCT05348564 is a NA study of Long QT Syndrome and Familial Hypercholesterolemia that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 200 participants, below the 653-participant average among 7 other Long QT Syndrome trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05348564, a NA study of Long QT Syndrome and Familial Hypercholesterolemia, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are identified, also known as cascade screening. Most cascade screening studies conducted to date have been conducted outside the US, and very few studies have used a rigorous approach involving a comparator group or randomized controlled design. A major question in the field is how to most effectively implement cascade screening, given commonly cited communication barriers, while respecting privacy among probands and family members. This study will conduct a randomized controlled trial to assess direct contact of relatives by study team members vs indirect, or proband-initiated, contact. We will assess efficacy of the cascade screening intervention, patient-centered outcomes regarding mental, physical, and psychosocial outcomes in probands and family members, and implementation evaluation outcomes. Individuals who are known to carry the KCNQ1 Met224Thr or APOB Arg3527Gln variant will be eligible to participate. After providing consent and being deemed eligible, individuals will be randomized in a 1:1 manner into the direct or indirect contact of family members arm of the study. The randomization will be stratified by variant to ensure equal representation of each variant in the study arms. Individuals in the indirect arm will be instructed to contact their first-degree family members about the opportunity to be screened. They will be provided with a disease-specific pamphlet and a family letter explaining the cascade screening. In the direct arm, probands will be advised that the study staff will be contacting their family members. They will be instructed to also contact their family members prior to the study team contacting them. Approximately two weeks after this meeting with the proband, the study staff will mail letters to eligible first-degree family members of the probands. If we do not hear back from indiv
Primary Outcome
Proportion of first-degree relatives who undergo testing/All eligible first-degree relatives
Conditions Studied
Interventions
- BEHAVIORAL Direct contact of family members for cascade screening of relevant variants
Study Locations (1)
Pennsylvania
- University of Maryland Amish Research Clinic - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT05348564 shows while recruiting
NCT05348564 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 653-participant average among 7 other Long QT Syndrome trials with a reported enrollment target (69% lower).
The record links to 4 conditions, with Long QT Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Direct contact of family members for cascade screening of relevant variants is the first listed.
NCT05348564 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05348564 about?
NCT05348564 is a clinical study titled "Comparing Direct vs Indirect Methods for Cascade Screening". An important aspect of successful genomic medicine implementation is developing effective approaches for screening at-risk family members after probands are identified, also known as cascade screening. Most cascade screening studies conducted to date have been conducted outside the US, and very few ...
What is the current status of trial NCT05348564?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-05-15. Estimated completion is 2027-03.
What conditions does trial NCT05348564 study?
This clinical trial studies the following conditions: Long QT Syndrome, Familial Hypercholesterolemia, Genetic Testing, Ethics.
What interventions are being tested in trial NCT05348564?
The interventions under investigation include: Direct contact of family members for cascade screening of relevant variants (BEHAVIORAL).
Who is sponsoring clinical trial NCT05348564?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05348564 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long QT Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Versus Intermittent cARdiac Electrical moNitorinG
RECRUITING · NA
-
Long QT Syndrome and Sleep Apnea
COMPLETED · NA
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults
COMPLETED · Phase 1
-
Exercise in Genetic Cardiovascular Conditions
COMPLETED
-
Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI